Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities."

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

The Allegations: Robbins LLP is Investigating Allegations that Agilon Health, Inc. (AGL) Misled Investors Regarding its Business Prospects

According to the complaint, defendants failed to disclose that they recklessly issued guidance for 2025 that they knew or should have known was not going to be achieved, given material industry headwinds of which they were aware, and materially overstated the immediate positive financial impact from “strategic actions” taken by agilon to reduce risk.

On August 4, 2025, agilon issued a press release announcing that Steven Sell had stepped down as President, CEO and a Director of the Board. Plaintiff alleges that the Company's form 8-K filed with the SEC stated that "Mr. Sell's departure was a termination without 'cause' under Mr. Sell's employment agreement[.]" The complaint further alleges that on August 4, 2025, agilon issued disappointing financial results. On this news, the price of the Company's stock fell over 50%, to close at $0.8801 on August 5, 2025.

What Now: You may be eligible to participate in the class action against agilon health, inc. Shareholders who wish to serve as lead plaintiff for the class should contact Robbins LLP. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.

To be notified if a class action against agilon health, inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251231115740/en/

Robbins LLP is Investigating Allegations that Agilon Health, Inc. (AGL) Misled Investors Regarding its Business Prospects